COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Limelight Bio, a multi-platform biopharma developing gene therapies and editing technologies, employs methods to correct genetic defects across retinal, hematologic, metabolic, neurologic, and hearing-loss diseases without permanent genomic alteration.
